Aurora kinase inhibitors in preclinical and clinical testing

By Cheung Chun Hei Antonio   Coumar Mohane Selvaraj   Hsieh Hsing-Pang   Chang Jang-Yang  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 379-398

Informa Healthcare

Access to resources Recommend Favorite

Danusertib, an aurora kinase inhibitor

By Meulenbeld Hielke J   Mathijssen Ron HJ   Verweij Jaap   de Wit Ronald   de Jonge Maja JA  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 383-393

Informa Healthcare

Access to resources Recommend Favorite

Update on aurora kinase targeted therapeutics in oncology

By Green Myke R   Woolery Joseph E   Mahadevan Daruka  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 3, 2011-03 ,pp. : 291-307

Informa Healthcare

Access to resources Recommend Favorite

An integrated pharmacokinetic–pharmacodynamic model for an Aurora kinase inhibitor

By Kamei Hiroko   Jackson Robert   Zheleva Daniella   Davidson Fordyce  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 37, Iss. 4, 2010-08 ,pp. : 407-434

Springer Publishing Company

Access to resources Recommend Favorite

An update on anti-allergic patents granted in China: 2009 – 2011

By Zhang Shu   Zeng Xiaoning   He Shaoheng  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 715-734

Informa Healthcare

Access to resources Recommend Favorite